Showing results (61-70 of 99) with videos related to
Sort By:
Pageof 10
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1988
Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphyM Granowska, C C Nimmon, K E Britton, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
The bioavailability of oral intermediate-dose methotrexate. Effect of dose subdivision, formulation, and timing in the chemotherapy cycleV J Harvey, M L Slevin, R C Woollard, et al.European Journal of Cancer & Clinical Oncology|November 1, 1987
A randomized trial comparing vindesine and cisplatinum to vindesine and methotrexate in advanced non small cell lung carcinomaV J Harvey, M L Slevin, S P Cheek, et al.BMJ (Clinical Research Ed.)|July 9, 1994
Pursuit and practice of complementary therapies by cancer patients receiving conventional treatmentS M Downer, M M Cody, P McCluskey, et al.Investigational New Drugs|January 1, 1984
The pharmacokinetics of subcutaneous bolus cytosine arabinoside in an arachis oil plus aluminium distearate suspensionM L Slevin, E M Piall, A Johnston, et al.British Journal of Cancer|January 1, 1992
Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronideD Hucks, P I Thompson, L McLoughlin, et al.British Journal of Cancer|April 1, 1993
Tumour markers for prediction of survival and monitoring of remission in small cell lung cancerP W Johnson, S P Joel, S Love, et al.Seminars in Oncology|March 1, 1985
Single-dose etoposide in combination with vincristine and doxorubicin in the treatment of small-cell lung cancer (SCLC)A R Timothy, F M Calman, N T Bateman, et al.British Journal of Cancer|September 1, 1991
A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomasP W Johnson, P I Thompson, M T Seymour, et al.Pageof 10